| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 336 | 15.399 | 41.274 | 39.288 | 69.935 |
| Total Income - EUR | - | - | - | - | - | 336 | 16.285 | 47.995 | 42.228 | 71.989 |
| Total Expenses - EUR | - | - | - | - | - | 3.627 | 15.384 | 46.672 | 42.901 | 66.116 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -3.291 | 901 | 1.323 | -673 | 5.873 |
| Net Profit/Loss - EUR | - | - | - | - | - | -3.301 | 412 | 345 | -1.095 | 3.178 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - B&M Salvus Lab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 52 | 0 | 0 |
| Current Assets | - | - | - | - | - | 1.327 | 360 | 1.170 | 2.082 | 7.511 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 336 | 84 | 13 | 1.637 | 1.628 |
| Cash | - | - | - | - | - | 992 | 276 | 1.157 | 445 | 5.883 |
| Shareholders Funds | - | - | - | - | - | -3.260 | -2.776 | -2.461 | -3.549 | -340 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 4.587 | 3.135 | 3.682 | 5.630 | 7.852 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - B&M Salvus Lab S.r.l.